All News #Library
Biotech
Renalys Completes Phase III Trial Data Collection For Sparsentan
10 Oct 2025 //
PR NEWSWIRE
Renalys Completes Phase 3 Enrollment For Sparsentan In Japan
30 Jan 2025 //
PR NEWSWIRE

Market Place
Sourcing Support